Company profile
Cercare Medical A/S
Cercare Medical A/S has 1 AI-enabled medical device on the FDA list. The first decision was on June 22, 2026 and the most recent on June 22, 2026 (CMN Capillary Function with Oncology Virtual Expert). Its most common review panel is Radiology (1 device).
1AI devices
2026First decision
2026Latest decision
1Specialties
Timeline
- CMN Capillary Function with Oncology Virtual Expert · Radiology · QIH